Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rß2 or IL-18Rα.
Gene Ther
; 18(9): 898-909, 2011 Sep.
Article
in En
| MEDLINE
| ID: mdl-21451575
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Melanoma, Experimental
/
T-Lymphocytes
/
Genetic Therapy
/
Interleukin-12
/
Interleukin-18
/
Oncolytic Virotherapy
/
Receptors, Interleukin-12
/
Receptors, Interleukin-18
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Gene Ther
Journal subject:
GENETICA MEDICA
/
TERAPEUTICA
Year:
2011
Document type:
Article
Affiliation country:
Corea del Sur
Country of publication:
Reino Unido